Evidence map›Paper›PMID 39078851›Full record

ArticlePLoS pathogens2024

Erg251 has complex and pleiotropic effects on sterol composition, azole susceptibility, filamentation, and stress response phenotypes.

Xin Zhou, Audrey Hilk, Norma V Solis, Nivea Pereira De Sa, Bode M Hogan, Tessa A Bierbaum, Maurizio Del Poeta, Scott G Filler, Laura S Burrack, Anna Selmecki

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Xin ZhouDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Audrey HilkDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Norma V SolisDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States of America.
Nivea Pereira De SaDepartment of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
Bode M HoganGustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.
Tessa A BierbaumGustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.
Maurizio Del PoetaDepartment of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
Scott G FillerDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States of America.
Laura S BurrackGustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.
Anna SelmeckiDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0003-3298-2400

Funding

Lipid-mediated fungal pathogenesisR01AI125770 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI DEL POETA, MAURIZIO · 2016 to 2025
$6.2M
Aneuploidy and Acquired Antifungal Drug Resistance in Candida speciesR01AI143689 · NIAID · UNIVERSITY OF MINNESOTA · PI Anna M. Selmecki · 2020 to 2026
$3.2M
BLRD Research Career Scientist Award ApplicationIK6BX005386 · VA · NORTHPORT VA MEDICAL CENTER · PI DEL POETA, MAURIZIO · 2021 to 2025
–
BLRD VA IK6 BX005386NIAID NIH HHS R01 AI125770NIAID NIH HHS R01 AI143689
6 · The paper itself

Abstract

Ergosterol is essential for fungal cell membrane integrity and growth, and numerous antifungal drugs target ergosterol. Inactivation or modification of ergosterol biosynthetic genes can lead to changes in antifungal drug susceptibility, filamentation and stress response. Here, we found that the ergosterol biosynthesis gene ERG251 is a hotspot for point mutations during adaptation to antifungal drug stress within two distinct genetic backgrounds of Candida albicans. Heterozygous point mutations led to single allele dysfunction of ERG251 and resulted in azole tolerance in both genetic backgrounds. This is the first known example of point mutations causing azole tolerance in C. albicans. Importantly, single allele dysfunction of ERG251 in combination with recurrent chromosome aneuploidies resulted in bona fide azole resistance. Homozygous deletions of ERG251 caused increased fitness in low concentrations of fluconazole and decreased fitness in rich medium, especially at low initial cell density. Homozygous deletions of ERG251 resulted in accumulation of ergosterol intermediates consistent with the fitness defect in rich medium. Dysfunction of ERG251, together with FLC exposure, resulted in decreased accumulation of the toxic sterol (14-ɑ-methylergosta-8,24(28)-dien-3β,6α-diol) and increased accumulation of non-toxic alternative sterols. The altered sterol composition of the ERG251 mutants had pleiotropic effects on transcription, filamentation, and stress responses including cell membrane, osmotic and oxidative stress. Interestingly, while dysfunction of ERG251 resulted in azole tolerance, it also led to transcriptional upregulation of ZRT2, a membrane-bound Zinc transporter, in the presence of FLC, and overexpression of ZRT2 is sufficient to increase azole tolerance in wild-type C. albicans. Finally, in a murine model of systemic infection, homozygous deletion of ERG251 resulted in decreased virulence while the heterozygous deletion mutants maintain their pathogenicity. Overall, this study demonstrates that single allele dysfunction of ERG251 is a recurrent and effective mechanism of acquired azole tolerance. We propose that altered sterol composition resulting from ERG251 dysfunction mediates azole tolerance as well as pleiotropic effects on stress response, filamentation and virulence.

Indexed as

Antifungal AgentsCandida albicansCandidiasisDrug Resistance, FungalErgosterolFungal ProteinsAnimalsAzolesFluconazoleMiceMicrobial Sensitivity TestsPhenotypeSterolsStress, PhysiologicalAntifungal AgentsAzolesErgosterolFluconazoleFungal ProteinsSterols

Identifiers

PMID39078851
PMCPMC11315318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.